Cardiologia
Diretriz de consenso de especialistas sobre testes genéticos nas doenças cardíacas.
6 Abr, 2022 | 12:33hComunicado de imprensa: Recommendations on genetic testing for inherited cardiac diseases published today – European Society of Cardiology
Comentário no Twitter
#EHRA_ESC/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society Expert Consensus Statement on the state of genetic testing for cardiac diseases: https://t.co/CLL5EEuK6z#Europace #EHRA2022 @GerdHindricks @ABollmannMD #EPeeps #cardiotwitter pic.twitter.com/3hz4o5ynDh
— European Society of Cardiology Journals (@ESC_Journals) April 4, 2022
Estudo de coorte | Fatores de risco cardiovascular na infância e eventos cardiovasculares na vida adulta.
6 Abr, 2022 | 12:30hChildhood Cardiovascular Risk Factors and Adult Cardiovascular Events – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
Childhood cardiovascular risk factors including BMI, systolic blood pressure, lipid levels, and smoking were correlated with cardiovascular events in adulthood after a mean follow-up of 35 years. #ACC22 https://t.co/fh2SoQ09Qq pic.twitter.com/cZiYYGEubF
— NEJM (@NEJM) April 4, 2022
Efusão pericárdica e tamponamento cardíaco: dicas e armadilhas.
6 Abr, 2022 | 12:25hPericardial Effusion and Cardiac Tamponade: Pearls and Pitfalls – emDocs
Revisão sistemática | Reparo com cirurgia endovascular vs. cirurgia aberta para aneurismas aórticos toracoabdominais.
6 Abr, 2022 | 12:23h
Comentário no Twitter
New #CochraneEvidence – are patient outcomes better after endovascular or open surgical repair of #thoracoabdominal #aorticaneurysm ? #TAAA #VascSurg https://t.co/7FEeqMOb5c @FutureVascSurgn @CochraneLibrary @CochraneUK @NIHRresearch @ESVSmembership @VSGBI @VascularSVS pic.twitter.com/GexAw2EYL5
— CochraneVasc (@CochraneVasc) April 4, 2022
Estudo de coorte | Impacto da lesão miocárdica após cirurgia de revascularização do miocárdio no prognóstico de longo prazo.
6 Abr, 2022 | 12:16hConteúdo relacionado: Cohort Study: High-sensitivity Troponin I after cardiac surgery and 30-day mortality.
Comentário no Twitter
Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting https://t.co/RnTrSZN96l @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/DvR3LX38ji
— European Society of Cardiology Journals (@ESC_Journals) March 30, 2022
#ACC22 | Diretriz 2022 AHA/ACC/HFSA para tratamento de insuficiência cardíaca.
5 Abr, 2022 | 12:28hDiretriz ACC: Heart Failure
Resumo executivo: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Comunicado de imprensa: ACC, AHA, HFSA Issue Heart Failure Guideline – American Heart Association
Principais perspectivas: 2022 AHA/ACC/HFSA Heart Failure Guideline
Download de série de slides: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Comentário no Twitter
New ACC/AHA/HFSA clinical guideline provides patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with #HeartFailure.
Get the details in #JACC: https://t.co/zfbKMXxDNf#ClinicalGuidelines #HFrEF #CardioTwitter pic.twitter.com/hrvTj4TQUm
— JACC Journals (@JACCJournals) April 1, 2022
#ACC22 – Estudo randomizado | Tratamento para hipertensão crônica leve durante a gestação está associada com melhores desfechos gestacionais do que a estratégia de tratamento reservado somente para hipertensão grave.
5 Abr, 2022 | 12:25hTreatment for Mild Chronic Hypertension during Pregnancy – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
Treating chronic hypertension in early pregnancy benefits parents, babies – NIH News Releases
CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes – TCTMD
Comentário no Twitter
In pregnant women with mild chronic hypertension, targeting a blood pressure of < 140/90 mm Hg was associated with better pregnancy outcomes than a strategy of reserving treatment only for severe hypertension. #ACC22 https://t.co/fDrqa8uQiO pic.twitter.com/9KvogjnKcc
— NEJM (@NEJM) April 2, 2022
#ACC22 – Estudo randomizado | Entre pacientes ambulatoriais com insuficiência cardíaca, uma intervenção dietética para reduzir a ingestão de sódio não reduziu os eventos clínicos.
5 Abr, 2022 | 12:23hReduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial – The Lancet (necessário cadastro gratuito)
Comentários:
SODIUM-HF: No Impact of Dietary Salt Restriction on Death or Hospitalization – TCTMD
Comentário no Twitter
Nutritional counseling/strictly limiting sodium intake didn’t significantly reduce MACE in #HeartFailure patients in 6️⃣ countries, but did modestly improve QOL according to results of SODIUM-HF trial presented at #ACC22. https://t.co/ESjiy6g8a7 #ACCIntl #cvPrev #CardioNutrition pic.twitter.com/CjK6CfWNXg
— American College of Cardiology (@ACCinTouch) April 2, 2022
#ACC22 [Ainda não publicado] – Estudo randomizado | Mavacantem reduz a necessidade de intervenção cirúrgica em pacientes com cardiomiopatia hipertrófica obstrutiva.
5 Abr, 2022 | 12:10hComentários:
Mavacamten Slashes Need for Septal Reduction in Obstructive HCM: VALOR-HCM – TCTMD
Conteúdo relacionado: #ESCCongress – Randomized trial: Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy
Comentário no Twitter
ICYMI: The VALOR-HCM trial at #ACC22 showed that mavacamten improved symptoms & significantly reduced eligibility for needing septal reduction therapy (SRT) among symptomatic patients with obstructive #cvHCM. Check out the Trial Summary here: https://t.co/fXVp8H0bw5 @DLBHATTMD pic.twitter.com/f0gPp9dNX8
— American College of Cardiology (@ACCinTouch) April 2, 2022
Estudo de coorte de braço único | Ablação por radiofrequência intramiocárdica septal percutânea em pacientes com cardiomiopatia hipertrófica obstrutiva refratária a medicamentos.
5 Abr, 2022 | 12:08hPercutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy – JAMA Cardiology (gratuito por tempo limitado)
Comentário convidado: Septal Reduction Strategies in Hypertrophic Cardiomyopathy—The Scalpel, Catheter, or Wire? – JAMA Cardiology (gratuito por tempo limitado)
Vídeo: Percutaneous Intramyocardial Septal Radiofrequency Ablation
Comentário no Twitter
In this cohort study, percutaneous intramyocardial septal radiofrequency ablation was associated with a durable reduction in peak left ventricular outflow tract gradients. Medium-term follow-up saw improvement in symptoms with low morbidity and mortality. https://t.co/DiyLHPR0Bw
— JAMA Cardiology (@JAMACardio) April 1, 2022